Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. currently manages 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. This volume of 3 pending office actions suggests a focused patent portfolio. For a practitioner, managing 3 pending office actions requires a strategy that addresses the specific technical requirements of the Biotechnology & Pharmaceuticals sector while maintaining consistency across the applications. The concentration in this area defines the technical scope of the current filings.
The prosecution is distributed across 3 distinct examiners and 3 distinct art units. The busiest examiner, FOLEY, SHANON A, is responsible for 1 pending office action. Because there are 3 distinct examiners involved, the company's success is determined by the individual interpretations of several different officials. The presence of 3 distinct art units indicates that the technical subject matter is spread across specialized groups at the patent office. This structure allows for a diversified approach to the examination process.
Practitioners should monitor the 3 distinct art units to identify any common examination trends or prior art. With 3 distinct examiners, there is a need for clear communication to ensure that arguments made in one application are consistent with the rest of the 3 pending office actions. The individual workload of 1 pending office action for FOLEY, SHANON A represents one part of this focused prosecution effort. Success across these 3 distinct art units will require a deep understanding of the assigned examiners' styles.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FOLEY, SHANON A | 1 | 73.3% | +18.2% |
| SALVOZA, M FRANCO G | 1 | 68.2% | +30.6% |
| HORLICK, KENNETH R | 1 | 79.0% | +15.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18557247 | RECOMBINANT CEDAR VIRUS CHIMERAS | SALVOZA, M FRANCO G | 9d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18176909 | Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor | HORLICK, KENNETH R | 4d overdue |
| 18557247 | RECOMBINANT CEDAR VIRUS CHIMERAS | SALVOZA, M FRANCO G | 9d |
| 18739648 | IRRADIATION-INACTIVATED POLIOVIRUS, COMPOSITIONS INCLUDING THE SAME, AND METHODS OF PREPARATION | FOLEY, SHANON A | — |
| Art Unit | Apps |
|---|---|
| 1671 | 1 |
| 1672 | 1 |
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18739648 | IRRADIATION-INACTIVATED POLIOVIRUS, COMPOSITIONS INCLUDING THE SAME, AND METHODS OF PREPARATION | FOLEY, SHANON A | 1671 | §102§103§112DP | Non-Final OA | — | Pending | Jun 11, 2024 |
| 18557247 | RECOMBINANT CEDAR VIRUS CHIMERAS | SALVOZA, M FRANCO G | 1672 | §103§112 | Final Rejection | 9d | Pending | Oct 25, 2023 |
| 18176909 | Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor | HORLICK, KENNETH R | 1681 | §112 | Final Rejection | 4d overdue | Pending | Mar 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Shanon A Foley has the most, with 1 of The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
